top of page

Generations in healthcare. Backing the leaders who will define its next century.

We are an industrialist-backed, independent lead investor in high-tech healthcare and life sciences.  More than capital, we bring deep industry expertise and a powerful network to help innovators scale globally.

bg.png

Leveraging generations
of healthcare expertise, relationships and trust.

Rectangle 95.jpg
minimal_architectural_hallway_with_natural_202605131335 (1).png

Who we are

We partner with proven healthcare innovators ready to become global leaders, backing ambitious healthcare and life sciences companies that have moved beyond venture funding and are now scaling.

Our typical investments share:

SCALE

$10M + revenues, with organic growth of 50%+ per year

PROFITABILITY

Free-cash flow positive or near-profitable (within 12-18 months)

ALIGNMENT

Founder-led or management-owned businesses seeking a long-term, industry specialist partner

OUR OWNERSHIP

Majority or active minority with a board seat

FOCUS

Digital health, AI in healthcare and life sciences, medtech, bioprocessing

How we can help 

We do not invest in biotech, pharma (including generics and specialty pharma), classical payors, or traditional healthcare services.  Nor do we back persistently unprofitable or low-growth businesses.

globe-01_2X.png

US & GLOBAL EXPANSION

git-merge_2X.png

STRATEGIC ACQUISITIONS

line-chart-up-01_2X.png

PROFESSIONALISM

stars-01_2X.png

NEW PRODUCT LAUNCHES

Rectangle 95.jpg

Large cap solutions

We partner with founder- and family-led healthcare companies that are already leaders in their niches, on unlocking their next phase of global growth. 

 

Our typical partners demonstrate:

ESTABLISHED SCALE

Revenues of $500M–3B+ and EBITDA of $200M–1B+

STRONG MOMENTUM

Organic growth of 15–40%+ per year

OWNERSHIP ALIGNMENT

Founder, family, or management-owned businesses seeking a long-term partner

abstract_monochrome_editorial_photography,_smooth_202605131449 2.png
How we partner

With a powerful global network, we support our companies with:

SCALING & PROFESSIONALISM

SUCCESSION

EQUITY UP TO $1.5B, WITH DEBT FINANCING WHERE APPROPRIATE

LIQUIDITY

INTERNATIONAL EXPANSION  AND M&A

PREPARING FOR IPOs OR STRATEGIC EXITS

Our focus areas include:
  • Digitisation of pharma, medtech, diagnostics, care delivery, and payor systems

  • High-tech leaders in the pharma supply chain

  • Tools: bioprocessing, diagnostics, research

  • High-growth medtech niches

We do not invest in biotech, pharma (including generics and specialty pharma), classical payors, or traditional healthcare services.

The Evidence Investor

The Evidence Investor

Operating Capabilities:
Beyond Capital

We provide more than capital. With a powerful global network, at VSP Investments we help companies expand internationally, develop new capabilities, pursue M&A, and prepare for IPOs or strategic exits.

long_minimal_bridge_disappearing_into_202605131323.png

Local Roots,
Global Scale

Many of the best healthcare companies start with local excellence – in science, R&D or manufacturing.  We provide the capital, expertise, and networks to expand beyond borders and reach their full potential.

make_16_9_2K_202605131451 2.png

Global Expansion and Inorganic Growth

We help healthcare innovators tackle their biggest scaling challenges: entering and growing in the US market, and driving acquisitions – whether vertical, horizontal, or add-on – to accelerate growth.
 

make_16_9_2K_202605131455 2.png

Industry networks that open doors

Our global operator network spans from the C-suites and boards of leading healthcare firms to domain and regional experts. We mobilise this network for tailored expansion, professionalisation and long-term success.

Insights
Global Reach, Local Expertise
Global Reach
Contact Us

We live healthcare. It's in our DNA.

At VSP, we partner with high-tech healthcare and life sciences companies that have already proved their potential - and help them scale into global leaders. Capital is just the beginning. What sets us apart is heritage, deep industry knowledge, and a powerful global network.

If you're building the next wave of healthcare innovation, we'd love to hear from you.

ChatGPT Image May 6, 2026, 11_04_00 PM 1.png

Offices

Chamerstrasse 174

CH-6300 Zug

Switzerland

Email

Investor Relations

Press & Media Enquiries

bottom of page